Loading...

gpgpgp's Recent CancerCompass Activity

  • gpgpgp has replied to a post on the message board

    Three out of four biopsies do find no cancer. In case it does, what you describe should end up in a curable situation. gp

    September 04, 2018 view post
    • gpgpgp has replied to a post on the message board

      This doctor made a good presentation for Xofigo at a prostate cancer conference just before the warning was published: http://videolibrary-mirrorsmed.s3.amazonaws.com/prosca13/THM_09_Therapeutic%20landscape%20ADPC-2.mp4 You may want to watch it to learn about Xofigo.

      August 11, 2018 view post
      • gpgpgp has replied to a post on the message board

        In Europe there is a warning to use Xofigo: http://cancerology.blogspot.com/2018/07/restriction-of-xofigo-use-in-europe.html

        August 11, 2018 view post
        • gpgpgp has replied to a post on the message board

          In the newspaper report mentioned by CalBear it says: "While this treatment was pioneered in Germany four years ago...". Yes, this treatment is offered at most university hospitals in Germany now. The newspaper report mentions: "But a couple of months ago, Robyn noticed he had begun slowing down. Ten months had passed since his last treatment and when they looked at the new scan half the red had returned." Mos...

          August 11, 2018 view post
          • gpgpgp has replied to a post on the message board

            Raunova plus is a combination of Hydrochlorothiazide and Syrosingopine. There is a study called: "Potentiating the Hypotensive Effect of Hydrochlorothiazide With Syrosingopine", doi 10.1177/000331976001100304 So I do not think this is the right drug to get Syrosingopine. Same applies to Raunova plus which was made by Zambeletti in Italy and mentioned in the post by lightbulb.

            January 02, 2018 view post
            Loading...
            Load more activity
            Loading more activity

            About gpgpgp

            gpgpgp has not shared any information about themselves. Send them a message to tell them you'd like to find out more about them or add them as a friend.

            We care about your feedback. Let us know how we can improve your CancerCompass experience.